Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Lundbeck
Lundbeck
Lundbeck, Otsuka get positive opinion for schizophrenia drug
Reuters
Fri, 09/20/13 - 09:42 am
Otsuka
Lundbeck
Europe
schizophrenia
Abilify Maintena
Lundbeck recruiting 200-plus sales reps for Brintellix launch
Fierce Pharma
Wed, 08/7/13 - 10:19 am
hirings
Lundbeck
antidepressants
drug launches
Brintellix
Lundbeck’s Brintellix Is More Effective in Higher Dose in Study
Bloomberg
Sun, 05/19/13 - 11:19 am
Lundbeck
Brintellix
antidepressants
Lundbeck Jumps as Depression Drug Gets Praise
Bloomberg
Thu, 05/16/13 - 10:26 am
Lundbeck
Brintellix
antidepressants
Small Companies Are Leading Innovation For New Drugs To Treat Depression
Forbes
Tue, 05/7/13 - 11:31 am
clinical depression
Lundbeck
Alkermes
Novartis
Pfizer
AstraZeneca
Merck
Sanofi
Firm ranks top 5 biotech deals in evolving pharma R&D landscape
Fierce Biotech
Fri, 04/12/13 - 01:56 pm
biotech
M&A
Otsuka
Lundbeck
Gilead
Macrogenics
Roche
Chiasma
Edison Pharma
Dainippon
Moderna
AstraZeneca
Alzheimer's Drug Race Heats Up With Lundbeck Deal
Investors.com
Wed, 03/27/13 - 09:52 am
Lundbeck
Alzheimer's disease
Otsuka
Lu AE58054
Otsuka, Lundbeck Win Approval for Monthly Abilify Shot
Bloomberg
Fri, 03/1/13 - 11:12 am
schizophrenia
Lundbeck
Otsuka
Abilify
Abilify Maintena
Lundbeck given EU nod for alcohol dependence drug
Reuters
Thu, 02/28/13 - 11:43 am
Lundbeck
Europe
alcoholism
Selincro
Patients laud Lundbeck, Gilead, but give pharma's rep low marks
Fierce Pharma
Mon, 01/14/13 - 01:15 pm
patients
Lundbeck
Gilead
Lundbeck’s Anti-Alcoholism Pill Wins EU Regulatory Nod
Bloomberg
Fri, 12/14/12 - 11:50 am
Lundbeck
alcoholism
Selincro
Europe
Lundbeck gets U.S. nod for antidepressant submission
Reuters
Thu, 12/13/12 - 11:23 am
antidepressants
Lundbeck
vortioxetine
Lexapro
Lundbeck in Talks With Possible Alzheimer’s Drug Partners
Bloomberg
Fri, 10/19/12 - 11:34 am
Lundbeck
Alzheimer's disease
M&A
Acrescent
AE58054
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thu, 10/11/12 - 10:49 am
vortioxetine
Vectura
tofacitinib
Takeda
T-DM1
Sanofi
Roche
REGN727
Regeneron
Reata
QVA149
Pfizer
Odanacatib
Novartis
MorphoSys
Merck
macitentan
Lundbeck
Immunogen
GSK
GS-7977
Gilead
gantenerumab
Eliquis
darapladib
Bristol-Myers Squibb
Biogen Idec
BG-12
Bayer
Bardoxolone
Anacetrapib
Alpharadin
Algeta
Actelion
AbbVie
Lundbeck, Takeda seek U.S. approval for antidepressant
Chicago Tribune, IL
Tue, 10/2/12 - 12:17 pm
Takeda
Lundbeck
antidepressants
vortioxetine
Lundbeck to stop making cancer drug Elspar
Fierce Pharma
Wed, 09/19/12 - 11:43 am
Lundbeck
Elspar
leukemia
Lundbeck says FDA accepts review of schizophrenia drug
Reuters
Wed, 09/12/12 - 12:28 pm
Lundbeck
FDA
schizophrenia
aripiprazole
Lundbeck In Talks With Possible Alzheimer’s Drug Partners
Bloomberg
Wed, 08/8/12 - 10:45 am
Alzheimer's disease
Lundbeck
AE58054
‘Pay-for-Delay’ Drug Case Moves Forward
NY Times, NY
Wed, 07/25/12 - 11:27 pm
pay-for-delay
Lundbeck
Europe
The Race For The Next Blockbuster Schizophrenia Drug
Seeking Alpha
Thu, 07/19/12 - 08:39 am
schizophrenia
Eli Lilly
Addex
BioLineRx
Lundbeck
Targacept
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »